Cargando…

Targeting bile acids and lipotoxicity for NASH treatment

Detalles Bibliográficos
Autor principal:	Chiang, John Y. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721403/ https://www.ncbi.nlm.nih.gov/pubmed/29404437 http://dx.doi.org/10.1002/hep4.1127

Ejemplares similares

Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH
por: Tewari, Archana, et al.
Publicado: (2023)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
por: Sydor, Svenja, et al.
Publicado: (2020)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH
por: Dong, Jinrui, et al.
Publicado: (2021)

NASH-related increases in plasma bile acid levels depend on insulin resistance
por: Grzych, Guillaume, et al.
Publicado: (2020)

Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice
por: Zhou, Mei, et al.
Publicado: (2017)

Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
por: Radun, Richard, et al.
Publicado: (2021)

Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets
por: Ferrell, Jessica M., et al.
Publicado: (2019)

Protein Kinase Cβ: Linking Intestine Fibroblast Growth Factor 15 to Hepatic Extracellular Signal Regulated Kinase 1/2 Signaling in Bile Acid and Cholesterol Homeostasis
por: Chiang, John Y.L.
Publicado: (2015)

Lipotoxicity and Cytokine Storm in Severe Acute Pancreatitis and COVID-19
por: Hegyi, Péter, et al.
Publicado: (2020)

NASH: Connecting the dots with patients in mind
por: Cryer, Donna R.
Publicado: (2020)

Something to mTORC About in NASH
por: Finck, Brian N.
Publicado: (2022)

My lifelong dedication to bile acid research
por: Chiang, John Y.L.
Publicado: (2023)

NRF2 Induction for NASH Treatment: A New Hope Rises
por: Rojo de la Vega, Montserrat, et al.
Publicado: (2018)

Editorial: Lipotoxicity, mitotoxicity, and drug targets
por: Krako Jakovljevic, Nina, et al.
Publicado: (2023)

Letter from Dr. Nash
por: Hart, James A.
Publicado: (1875)

Bile Acid Signaling in Liver Metabolism and Diseases
por: Li, Tiangang, et al.
Publicado: (2012)

Regulation of Bile Acid and Cholesterol Metabolism by PPARs
por: Li, Tiangang, et al.
Publicado: (2009)

Lipotoxicity: Effects of Dietary Saturated and Transfatty Acids
por: Estadella, Débora, et al.
Publicado: (2013)

NASH‐related cirrhosis: An occult liver disease burden
por: Arrese, Marco, et al.
Publicado: (2017)

MerTK, a risk factor for NASH fibrosis
por: Wang, Xiaobo, et al.
Publicado: (2020)

Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
por: Fan, Weiguo, et al.
Publicado: (2021)

NASH and Systemic Complications: From Basic to Clinical Research
por: Baumgartner, Sabine, et al.
Publicado: (2021)

Exploiting lipotoxicity for the treatment of liver cancer
por: Rudalska, Ramona, et al.
Publicado: (2021)

Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease
por: Roh, Yoon Jin, et al.
Publicado: (2022)

Bile Acid Induced Inflammation and the Role of β-Catenin
por: Boyer, James L.
Publicado: (2023)

Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
por: Jansen, Peter L. M.
Publicado: (2021)

Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity
por: Ježek, Petr, et al.
Publicado: (2018)

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH mice
por: Zhai, Ting, et al.
Publicado: (2023)

Palmitic Acid Lipotoxicity in Microglia Cells Is Ameliorated by Unsaturated Fatty Acids
por: Urso, C.J., et al.
Publicado: (2021)

Ste20-like Kinase STK25: A Potential Target in Prevention and Therapy of NASH-Associated Hepatocellular Carcinoma?
por: Kühnel, Florian
Publicado: (2021)

Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
por: Vairetti, Mariapia, et al.
Publicado: (2022)

Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?
por: Tarantino, Giovanni
Publicado: (2013)

Osr1 Is a Critical Regulator of Macrophage Polarization in NASH Progression
por: Lee, Jin, et al.
Publicado: (2023)

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice
por: Liu, Szu-Yu, et al.
Publicado: (2022)

Recent advances in understanding bile acid homeostasis
por: Chiang, John YL
Publicado: (2017)

Lipotoxicity of Palmitic Acid on Neural Progenitor Cells and Hippocampal Neurogenesis
por: Park, Hee Ra, et al.
Publicado: (2011)

Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases
por: Jang, Hee-Seong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vmh81u8ro0p5r983d05e6tba4a